• 1. An all-solid-state imprinted polymer-based potentiometric sensor for determination of bisphenol S?
  Rongning Liang,Tanji Yin,Ruiqing Yao,Wei Qin RSC Adv., 2016,6, 73308-73312
• 2. An integrated digital microfluidic chip for multiplexed proteomic sample preparation and analysis by MALDI-MS?
  Hyejin Moon,Aaron R. Wheeler,Robin L. Garrell,Chang-Jin “CJ” Kim Lab Chip, 2006,6, 1213-1219
• 3. An anti-leakage liquid metal thermal interface material
  Kaiyuan Huang,Wangkang Qiu,Meilian Ou,Xiaorui Liu,Zenan Liao,Sheng Chu RSC Adv., 2020,10, 18824-18829
• 4. An assessment of strategies for the development of solid-state adsorbents for vehicular hydrogen storage
  Mark D. Allendorf,Alauddin Ahmed,Tom Autrey,Jeffrey Camp,Eun Seon Cho,Maciej Haranczyk,Abhi Karkamkar,Di-Jia Liu,Katie R. Meihaus,Iffat H. Nayyar,Roman Nazarov,Donald J. Siegel,Vitalie Stavila,Jeffrey J. Urban,Srimukh Prasad Veccham,Brandon C. Wood Energy Environ. Sci., 2018,11, 2784-2812
• 5. Aluminium complexes with thio-phosphorus ligands: syntheses and characterisations of [Al2(CyPS3)2(CyPHS2)2] and [Al(S2PPh2)3]?
  Robert P. Davies,Maria A. Giménez,Laura Patel,Andrew J. P. White Dalton Trans., 2008, 5705-5707

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Alkyl aryl ethers
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ethers Alkyl aryl ethers

Exploring the Versatility of (6-Chloro-5-methoxypyridin-3-yl)boronic acid (CAS No. 1548827-73-1) in Modern Chemistry

In the rapidly evolving field of organic synthesis and pharmaceutical research, (6-Chloro-5-methoxypyridin-3-yl)boronic acid (CAS No. 1548827-73-1) has emerged as a critical building block. This compound, characterized by its unique boronic acid functional group and pyridine backbone, plays a pivotal role in Suzuki-Miyaura cross-coupling reactions, a cornerstone of modern drug discovery and material science. Researchers and industry professionals are increasingly turning to this reagent for its efficiency in forming carbon-carbon bonds, a fundamental step in constructing complex molecular architectures.

The molecular structure of (6-Chloro-5-methoxypyridin-3-yl)boronic acid features a chloro substituent at the 6-position and a methoxy group at the 5-position of the pyridine ring. These modifications enhance its reactivity and selectivity in various transformations. With the growing demand for heterocyclic compounds in medicinal chemistry, this boronic acid derivative has gained significant attention for its potential in developing targeted therapies and bioactive molecules.

One of the most compelling applications of 1548827-73-1 lies in the pharmaceutical industry, where it serves as a key intermediate in the synthesis of small molecule inhibitors and kinase modulators. Recent studies highlight its utility in creating compounds with potential anti-inflammatory and anticancer properties. The compound's compatibility with green chemistry principles also makes it attractive for sustainable drug development, aligning with the global push for environmentally friendly synthesis methods.

Beyond pharmaceuticals, (6-Chloro-5-methoxypyridin-3-yl)boronic acid finds applications in material science, particularly in the development of organic electronic materials and liquid crystals. Its ability to participate in palladium-catalyzed reactions enables the construction of conjugated systems essential for OLEDs and photovoltaic devices. This versatility addresses the increasing need for high-performance materials in renewable energy technologies.

The synthesis and handling of 1548827-73-1 require careful consideration of its physicochemical properties. With a molecular weight of 187.42 g/mol, this white to off-white crystalline powder typically exhibits good stability under standard conditions. However, like many boronic acids, it may undergo protodeboronation under certain conditions, necessitating proper storage in cool, dry environments. These characteristics are crucial for researchers optimizing reaction conditions in high-throughput screening and combinatorial chemistry.

Market trends indicate growing demand for (6-Chloro-5-methoxypyridin-3-yl)boronic acid, driven by expanding research in personalized medicine and precision therapeutics. Suppliers are responding with improved purity grades and custom synthesis options to meet diverse research needs. The compound's structure-activity relationship potential continues to inspire novel applications in drug design, particularly for challenging targets like protein-protein interactions.

Quality control remains paramount when working with CAS 1548827-73-1. Advanced analytical techniques such as HPLC, NMR, and mass spectrometry ensure batch-to-batch consistency, critical for reproducible research outcomes. The compound's spectral data and chromatographic profiles have been well-characterized, providing valuable references for quality assessment in both academic and industrial settings.

Looking ahead, (6-Chloro-5-methoxypyridin-3-yl)boronic acid stands poised to contribute to breakthroughs in bioconjugation chemistry and theragnostic development. Its compatibility with click chemistry approaches opens possibilities for creating multifunctional probes and drug delivery systems. As synthetic methodologies advance, this compound will likely play an expanding role in addressing current challenges in medicinal chemistry and chemical biology.

For researchers seeking reliable sources of 1548827-73-1, it's essential to partner with suppliers who provide comprehensive technical data sheets and safety information. Proper documentation of handling procedures and storage recommendations ensures safe laboratory practices while maximizing the compound's utility in diverse synthetic applications.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)